Aquestive is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems.
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Aquestive is committed to addressing immediate CNS challenges by furthering its strong pipeline of products. As the undisputed leader in developing and delivering drugs via its proprietary technologies, the Company also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 25, 2008 | Debt Financing | $20M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Edward P. Bass Group | — | Debt Financing |